Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CORESTEM is a global stem cell biotechnology company that holds growth, momentum and stability through continuous research and development in the field of stem cell therapy since it established in 2003. We have focused on research and development which was founded by a variety of researchers in the field of biotechnology to develop stem cell therapeutics for neurodegenerative disorder and autoimmune disease. As a results of ou...
CORESTEM is a global stem cell biotechnology company that holds growth, momentum and stability through continuous research and development in the field of stem cell therapy since it established in 2003. We have focused on research and development which was founded by a variety of researchers in the field of biotechnology to develop stem cell therapeutics for neurodegenerative disorder and autoimmune disease. As a results of our efforts, CORESTEM have developed NEURONATA-R inj., a stem cell therapy of Lou Gehrig's disease which is a rare incurable disease, for the first ALS treatment in the world.

List your booth number for exhibitions, ask us